Discovery, Pharmacological Characterisation and NMR Structure of the Novel µ-Conotoxin SxIIIC, a Potent and Irreversible NaV Channel Inhibitor
Kirsten L. McMahon(The University of Queensland), Christina I. Schroeder(Research Institute for Bioscience and Biotechnology), Irina Vetter(Centre National de la Recherche Scientifique), Richard J. Lewis(AstraZeneca (Netherlands)), Hue N. T. Tran(The University of Queensland), Jennifer R. Deuis(The University of Queensland)
Cited by 19
Related Papers
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
|Nature Medicine|2015|2.8k
Methods Used to Evaluate Pain Behaviors in Rodents
|Frontiers in Molecular Neuroscience|2017|1.3k
Therapeutic potential of venom peptides
|Nature Reviews Drug Discovery|2003|786
Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
|Frontiers in Molecular Neuroscience|2017|654
Conus Venom Peptide Pharmacology
|Pharmacological Reviews|2012|422